Antiretroviral Program Management Issues in Low Resource Set-
tings: A Training Seminar for Policy Makers & Program Managers
--------------------------------------------------------------
7 - 18 August, 2006
Boston, MA USA
WHO Collaborating Center in Pharmaceutical Policy and Boston
University Seminar
http://international-health.org
Background
Funding through Global Fund, PEPFAR, and other initiatives has
recently transformed AIDS into a treatable disease in developing
and transitional countries. Resources such as ARVs and diagnos-
tics are now available; however, rapid scale-up of AIDS treat-
ment programs has not occurred, in part, due to ARV drug manage-
ment issues. ARV drug management issues include difficulties
with pharmaceutical supply systems and logistics, insufficient
human resources to provide ART and barriers to ARV adherence.
Seminar Overview
Week One (August 7-11, 2006): Drug Management Key Issues
A description of the various national and international players
involved in ARV management will be discussed with recommenda-
tions to efficiently coordinate efforts. Specific drug manage-
ment issues to be covered include: evidence-based selection of
medications, quantification, procurement, pricing, quality as-
surance, pre-qualification of suppliers and monitoring and
evaluation.
Week 2 (August 14-18, 2006): ARV Adherence
An overview of adherence issues will be followed by instruction
on how to measure ARV adherence. Approaches to improve adherence
to AIDS and other chronic diseases will be presented. A field
visit to an ARV adherence clinic will allow participants an op-
portunity and interact with health care practitioners (pharma-
cists, physicians, nurses, social workers, nutritionists) in-
volved in ARV adherence activities.
Who Should Attend?
Policy makers, ARV Program Managers, and NGO Officials responsi-
ble for national and local programs. Social scientists, pharma-
cists, and other public health professionals interested in ARV
management and adherence.
Teaching Methods
Instruction will occur in English. The format will be highly in-
teractive with presentations by international experts followed
by facilitated group exercises and discussion. Case studies and
guided readings will be provided and substantial preparation is
required for each session. A field visit to an ARV Adherence
Clinic will be arranged.
Faculty
Brenda Waning, Boston University School of Public Health; Rich-
ard Laing MD, World Health Organization, Geneva.
Fees
Conference costs (no academic credit): US$ 1,282 includes tui-
tion and materials fee.
For more information, contact
Sarah Petty
mailto:spetty@bu.edu or
or by phone: +1-617-638-5234